Simple Summary Molecular directed therapy for hepatocellular carcinoma (HCC) involves
targeting specific signaling pathways that normally promote cancer cell growth and survival …

Background Diabetes mellitus is a significant health problem worldwide, often leading to
diabetic kidney disease (DKD), which may also influence the occurrence of hepatocellular …

Liver malignancy is well recognized as a prominent health concern, with numerous
treatment options available. Natural products are considered a renewable source, providing …

Introduction Hepatocellular carcinoma (HCC) is one of the common malignant tumors.
Although surgical resection is the best treatment for HCC, many patients with HCC are found …

Background/Aim: Liver cancer is one of the malignancies with the highest mortality-to-
incidence ratio worldwide. Therefore, novel therapeutic approaches are urgently needed …

Colorectal Carcinoma (CRC) is one of the most common malignant tumors of the digestive
tract, with a high mortality rate. DPY30 is one of the core subunits of the histone …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related morbidity
and mortality worldwide. Current therapeutic approaches suffer significant side effects and …

Abstract Dynactin subunit 2 (DCTN2) has been reported to play a role in progression of
several tumours; however, the involvement of DCTN2 in potential mechanism or the tumour …

According to the alarming statistical analysis of global cancer, there are over 19 million new
diagnoses and more than 10 million deaths each year. One such cancer is the oral …

Background Hepatocellular carcinoma (HCC) with high Ki67 protein expression, the most
commonly used cell proliferation marker, is associated with an aggressive biologic …